NEW YORK (GenomeWeb News) – Soft sales during the third quarter has forced Molecular Devices to cut its financial guidance for the period by between 8 percent and 12 percent, the company said today.
 
Molecular Devices said it now expects revenue for the three months ended Sept. 30 to be between $44 million and $46 million. In July the company said it expected to generate between $48 million and $52 million in the period.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.